Ultrasound Assessment of Diaphragmatic Dysfunction in Regional Anesthesia

Status Completed

Clinical Trial Summary

Clinical Trial Description

Awake thoracic surgery is a feasible and safe alternative to general anesthesia for pulmonary biopsy in interstitial lung disease patients, but there is still no evidence as to its superiority in terms of outcome. However, there is extensive literature about the effect of anesthetic drugs and surgery on diaphragmatic function. Furthermore, in thoracic surgery, diaphragmatic dysfunction was associated with a higher occurrence of postoperative pulmonary complications. To assess the impact of general anesthesia on diaphragmatic function, the investigators conducted an observational prospective trial. The investigators measured both diaphragmatic excursion and Thickening Fraction at baseline and 12 hours after surgery together with pulmonary function tests and gas exchange data. The investigators divided our population into two groups: one group of patients undergoing awake thoracic surgery with epidural anesthesia, and the other group undergoing general anesthesia. Forty-one patients were recruited and the Thickening Fraction percentage, calculated as (End Inspiratory thickness-End Expiratory thickness)/End Expiratory thickness, was evaluated by means of an ultrasound-assisted method, using a high frequency (10 MHz) linear probe. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04700943
Study type	Observational
Source	University of Turin, Italy
Contact
Status	Completed
Phase
Start date	February 1, 2019
Completion date	January 1, 2021

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04865874` - GDT-PPV Protocol in Thoracic Surgery	N/A
Active, not recruiting	`NCT02715271` - Study of TB Lesions Obtained in Therapeutical Surgery
Completed	`NCT02919267` - Physiology of Lung Collapse Under One-Lung Ventilation: Underlying Mechanisms	N/A
Completed	`NCT02964026` - Study of Clinical Outcomes Associated With the Pulmonary Artery Catheter (PAC) in Cardiac Surgery Patients	N/A
Recruiting	`NCT03165539` - Cerebral Oxygen Desaturation and Post-Operative Delirium in Thoracic Surgical Patients
Terminated	`NCT01320475` - Epidural Levobupivacaine-sufentanil Versus Epidural Levobupivacaine and Intravenous Ketamine	Phase 4
Recruiting	`NCT05045196` - Health-promoting Family Conversations and Open Heart Surgery	N/A
Completed	`NCT04507958` - Electronic Stethoscope Use During Intubation in Full Personal Protective Equipment
Recruiting	`NCT05060302` - Prognosis of Right Ventricular Dysfunction Assessed by Speckle Tracking in Postoperative Thoracic Surgery	N/A
Completed	`NCT05667467` - The Effect of Care Bundle in Heart Surgery	N/A
Not yet recruiting	`NCT03275428` - THRIVE and Non-intubated Thoracic Surgery	N/A
Not yet recruiting	`NCT05482230` - Application of Tracheal Intubation in Lateral Position in Thoracic Surgery	N/A
Enrolling by invitation	`NCT04429009` - A Randomized Control Trial of ZEPHYRx Gamified Incentive Spirometry Compared to Traditional Spirometry	N/A
Not yet recruiting	`NCT03628040` - Erector Spinae Plane Block for Video-assisted Thoracoscopic Surgery	Phase 3
Recruiting	`NCT03300622` - Assessment in Patients After Thoracic Surgery	N/A
Completed	`NCT00981474` - Cerebral Autoregulation Monitoring During Cardiac Surgery	N/A
Completed	`NCT03309280` - Influence of Different Parameters on Extubation Time After Cardiac Surgery.
Recruiting	`NCT03820700` - Using Hypnosis and Virtual Reality During Pre and Postoperative Cardiovascular Surgery.	N/A
Completed	`NCT03768193` - Deep Serratus Anterior Plane Block vs Surgically-placed Paravertebral Block for VATS Surgery	N/A
Recruiting	`NCT04609228` - Cardiac Surgery Outcomes in Blood-transfusion Acceptors and no Acceptors

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.